The Universal Journal of Emerging Infectious Diseases and Rare Diseases (UJEIRD) is published monthly. UJEIRD is a non profit, peer-reviewed, open access journal and publishes original articles in relevant areas including common infectious diseases including bacterial and viral emerging diseases, outbreaks, all communicable and non communicable diseases. Clinical and Laboratory-based research, together with reports of clinical trials, reviews, and some case reports dealing with the epidemiology, clinical diagnosis, treatment, and control of infectious diseases with particular emphasis placed on those diseases that are most common in under-resourced countries. The main agenda of this journal is to spread the innovative research carried out by the researchers and scientists across in the field of microbiology, infectious diseases, virology, bacteriology, mycology, vaccines and biomedical research across the World. Besides, the Infectious Diseases, we are accepting articles relevant to Rare Diseases. Rare disease in general affects a small percentage of the population. In some parts of the world, an orphan disease is a rare disease whose rarity means there is a lack of a market large enough to gain support and resources for discovering treatments for it, except by the government granting economically advantageous conditions to creating and selling such treatments. Orphan drugs are ones so created or sold.
Most of the rare diseases are genetically associated and thus are present throughout the person's entire life, even if symptoms do not immediately appear. Many rare diseases appear early in life, and about 30% of children with rare diseases will die before reaching their fifth birthday. With only three diagnosed patients in 27 years, ribose-5-phosphate isomerase deficiency is considered the rarest known genetic disease.
No single cut-off number has been agreed upon for which a disease is considered rare. A disease may be considered rare in one part of the world, or in a particular group of people, but still be common in another.
The US organisation Global Genes has estimated that more than 300 million people worldwide are living with one of the approximately 7,000 diseases they define as "rare" in the United States.
The Editorial Board
Zeng Xu, University of Florida, United States
Alireza Heidari, California South University, United States
Yarla, Novel Global Education Foundation, NSW, Australia.
Member, American cancer association, United States
Oner Ozdemir, Göztepe Teaching and Training Hospital, Turkey
Sivakumar Joghi Thatha Gowder, Ton Duc Thang University, Vietnam
Viroj Wiwanitkit, Hainan Medical University, China
Abdulghani Alsamarai, Tikrit University, Iraq
Bhola Nath, AIIMS, India
Naim Deniz Ayaz , Risk Assessment Commission of Contaminants, Turkey
Elena Germanovna Dmitrieva, Cand.biol.science’s for Clinical Pharmacology, Russia
Our Associations & Collaborations
More Info: www.opti-my-wise-life.myshopify.com/password
More Info: www.medicalarrow.com
Medvoyage Tourism & Education
More Info: www.medicalarrow.com
More Info: www.medproinfo.com
More Info: www.researchbib.com
World Conference Alerts
More Info: www.worldconferencealerts.com
Course for Doctors
More Info: www.coursefordoctors.com
Sivakumar J T Gowder
Volume - 1, Issue - 1
Marwa M. Elmaghrabi
Volume - 1, Issue - 2